1-4 of 4
Authors: Kristyna Kastylova
Journal Article
EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S78, https://doi.org/10.1093/ibd/izac247.150
Published: 26 January 2023
Journal Article
SUBCUTANEOUS INFLIXIMAB IN REFRACTORY CROHN'S DISEASE PATIENTS AFTER THE MULTIPLE TREATMENT FAILURES - SHORT TREATMENT OUTCOMES
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S76, https://doi.org/10.1093/ibd/izac247.146
Published: 26 January 2023
Journal Article
DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY BOWEL DISEASES: DATA FROM CLINICAL PRACTICE
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S105, https://doi.org/10.1093/ibd/izac015.170
Published: 22 January 2022
Journal Article
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study
Inflammatory Bowel Diseases, Volume 28, Issue 10, October 2022, Pages 1506–1512, https://doi.org/10.1093/ibd/izab301
Published: 30 November 2021
